E I Du Pont De Nemours And Co  

(Public, NYSE:DD)   Watch this stock  
68.43
+0.58 (0.85%)
Jul 22 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 67.65 - 68.63
52 week 47.11 - 75.72
Open 67.89
Vol / Avg. 1.78M/3.22M
Mkt cap 59.92B
P/E 28.91
Div/yield 0.38/2.22
EPS 2.37
Shares 873.97M
Beta 1.77
Inst. own 71%
Jul 26, 2016
Q2 2016 E I du Pont de Nemours and Co Earnings Release - 9:30AM EDT - Add to calendar
Jul 26, 2016
Q2 2016 E I du Pont de Nemours and Co Earnings Call - 8:00AM EDT - Add to calendar
Jun 9, 2016
E I du Pont de Nemours and Co at Deutsche Bank Global Industrials and Materials Summit
May 12, 2016
E I du Pont de Nemours and Co Annual Shareholders Meeting (Estimated)
May 10, 2016
E I du Pont de Nemours and Co at Wells Fargo Industrial and Construction Conference
Apr 27, 2016
E I du Pont de Nemours and Co Annual Shareholders Meeting
Apr 26, 2016
Q1 2016 E I du Pont de Nemours and Co Earnings Release
Apr 26, 2016
Q1 2016 E I du Pont de Nemours and Co Earnings Call
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '16) 2015
Net profit margin 16.47% 7.50%
Operating margin 19.07% 9.30%
EBITD margin - 17.80%
Return on average assets 11.88% 4.14%
Return on average equity 49.21% 16.45%
Employees 52,000 -
CDP Score - 99 B

Address

974 Centre Rd
WILMINGTON, DE 19805-1269
United States - Map
+1-302-7741000 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
About Company - Wikipedia

Description

E. I. du Pont de Nemours and Company (DuPont) is a science and technology-based company. The Company consists of over 10 businesses aggregated into six segments: Agriculture, Electronics & Communications, Industrial Biosciences, Nutrition & Health, Performance Materials and Safety & Protection. Its products include corn hybrids and soybean varieties, herbicides, fungicides and insecticides in Agriculture segment; photopolymers and electronic materials in Electronics & Communications segment; enzymes and bio-based materials in Industrial Biosciences segment; cultures, emulsifiers, texturants, natural sweeteners and soy-based food ingredients in Nutrition & Health segment; engineering polymers, packaging and industrial polymers, films and elastomers in Performance Materials segment, and nonwovens, aramids and solid surfaces in Safety & Protection segment. It is also involved in other businesses, such as pre-commercial programs, nonaligned businesses and pharmaceuticals in other.

Officers and directors

Edward D. Breen Chairman of the Board, Chief Executive Officer
Age: 60
Bio & Compensation  - Reuters
Nicholas Charles Fanandakis Chief Financial Officer, Executive Vice President
Age: 59
Bio & Compensation  - Reuters
James C. Collins Jr. Executive Vice President
Age: 53
Bio & Compensation  - Reuters
C. Marc Doyle Executive Vice President
Age: 46
Bio & Compensation  - Reuters
Stacy L. Fox Senior Vice President, General Counsel
Age: 62
Bio & Compensation  - Reuters
Benito Cachinero-Sanchez Senior Vice President - Human Resources
Age: 57
Bio & Compensation  - Reuters
Douglas W. Muzyka Senior Vice President and Chief Science & Technology Officer
Age: 61
Bio & Compensation  - Reuters
Lamberto Andreotti Independent Director
Age: 65
Bio & Compensation  - Reuters
Robert A. Brown Independent Director
Age: 64
Bio & Compensation  - Reuters
Alexander M. Cutler Independent Director
Age: 64
Bio & Compensation  - Reuters